Celgene, Lilly, Biogen-Idec: Part Of Monday Healthcare Lineup
Okay, the real "Granddaddy of 'em all" was actually this past Tuesday at the Rose Bowl (I promise that's my last reference to the amazing USC Trojans unless they win a split national championship), but the granddaddy of healthcare investment conferences begins on Monday in San Francisco.

JPMorgan's 26th annual event will feature more than 300 presentations from private and public companies, nearly 5,000 one-on-one company/investor meetings and nearly 8,000 attendees.

It's the first and biggest healthcare conference of the year, the place to see and be seen for anyone who's anyone in healthcare investing. It runs through next Thursday, but we'll only be doing live reports and interviews from there on Monday.

We received dozens of pitches from PR people to put the CEO of their company or the companies they represent on CNBC Monday. This is one example where we have no problem finding people willing to be interviewed.

Although a couple of the "gets" I wanted didn't come through for a variety of reasons--the previously-documented Amgen,Genentech,Medicis and Allergan, just to name a few. We've tried to book a cross-section of CEOs, most of them with companies that have major events anticipated in the new year. So, as promised, here's our lineup: